March 4, 2025 · Form 4 insider transaction
Tatsis Ourania sold 4,058 shares of Vertex Pharmaceuticals Incorporated at $485.49 per share, a transaction worth $1.97M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 11/22/2024.